NIKANIKA PHARMACEUTICALS INC.

About NIKA PHARMACEUTICALS INC. (NIKA)

NIKA PHARMACEUTICALS INC. (NIKA) is a Drug Manufacturers - Specialty & Generic company headquartered in Henderson, NV, United States whose shares trade over-the-counter on the OTCQB tier.

Nika Pharmaceuticals, Inc. (NIKA) is a pharmaceutical company, which specializes in the treatment of HIV/AIDS, Chronic Hepatitis B and C, Rheumatoid Arthritis, Cancer, Diabetes, and all diseases, for which a strengthened cell immunity is of vital importance. NIKA specializes in the field of scientific research with the goal of creating and developing new drugs and dietary supplements. At this moment in time, NIKA's intellectual property includes six drugs in injection form - two of which have successfully undergone clinical trials with good treatment results - four drugs in tablet form, and eleven dietary supplements. The goal of NIKA is to not only achieve corporate profits, but to also improve the quality of life of the population by providing better and easier access to life-saving medicinal drugs and useful dietary supplements.

Products and services

ITV-1 is a injection form drug, which has undergone a clinical trial on 31 patients suffering from AIDS and has shown significant usefulness in terms of treatment effect and lower cost to patients. TNG is presented in the form of 16 injections. A treatment of AIDS with TNG requires only 2 sets of TNG and TNG has also undergone successful clinical trials. Physiolong is an original biostimulator, comprised of natural biologically active substances with a favorable rapid effect on the energy balance of the human organism. Carotilen regulates the metabolism of the epithelial cells and protects them from degenerative alterations. It may be used in cases of avitaminosis – A malnutrition or intestinal resorption impairment. Fructin is a healing food with insulin-independent action, which has very good hepatoprotective, cardioprotective and general bio stimulating effect. Hypocholestin is a dietary supplement that reduces the high levels of bad cholesterol in the blood (LDL) and in particular very high density lipoproteins, as well as triglycerides. Dry Boza is a soft drink in dry granular form that contains all essential amino acids and very little fat that is suitable for people predisposed to obesity and atherosclerosis. Biodetoxin is a dietary supplement used in cases of severe intoxication from toxic substances taken orally or at inhalation in a dusty environment. Anthocylen C is an effective healing dietary supplement used for prevention and treatment of radiation sickness.

NIKA key facts

Ticker symbol

NIKA

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Henderson, NV, United States

Country of incorporation

US

Year of incorporation

2000

Employees

2

Estimated market cap

$1.03B (as of May 13, 2025)

Shares outstanding

1,026,371,000

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

NIKA PHARMACEUTICALS INC. leadership

• Dimitar Slavchev Savov — CEO, President, CFO
• Clifford Paul Redekop — Secretary

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with N